# MARAVAI LIFESCIENCES HOLDINGS, INC.

MARAVAI LIFESCIENCES HOLDINGS, INC. is a public company listed on Nasdaq as MRVI, headquartered in San Diego, CA, United States.

## Company overview

- **Legal name:** MARAVAI LIFESCIENCES HOLDINGS, INC.
- **Classification:** Public company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** San Diego, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **Ticker:** Nasdaq: MRVI
- **SEC CIK:** 0001823239

## About

MARAVAI LIFESCIENCES HOLDINGS, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001823239, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2026-02-26, it reported annual revenue of USD 185,743,000; net income of USD -130,773,000; total assets of USD 770,577,000 for the fiscal period ended 2025-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2025 (period ended 2025-12-31)

- **Revenue:** $185.7M (USD 185,743,000)
- **Net income:** -$130.8M (USD -130,773,000)
- **Total assets:** $770.6M (USD 770,577,000)
- **Cash and equivalents:** $216.9M (USD 216,890,000)
- **Operating cash flow:** -$57.6M (USD -57,573,000)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

### FY2024 (period ended 2024-12-31)

- **Revenue:** $259.2M (USD 259,185,000)
- **Net income:** -$144.8M (USD -144,846,000)
- **Total assets:** $1.0B (USD 1,008,244,000)
- **Cash and equivalents:** $322.4M (USD 322,399,000)
- **Operating cash flow:** $7.5M (USD 7,465,000)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

### FY2023 (period ended 2023-12-31)

- **Revenue:** $288.9M (USD 288,945,000)
- **Net income:** -$119.0M (USD -119,029,000)
- **Total assets:** $1.5B (USD 1,487,450,000)
- **Cash and equivalents:** $575.0M (USD 574,962,000)
- **Operating cash flow:** $126.2M (USD 126,224,000)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

### FY2022 (period ended 2022-12-31)

- **Revenue:** $883.0M (USD 883,001,000)
- **Net income:** $220.2M (USD 220,205,000)
- **Total assets:** $2.3B (USD 2,282,315,000)
- **Operating cash flow:** $536.0M (USD 535,977,000)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 10-Q — filed 2026-08-07 — period 2026-06-30 — 10-Q
- Form 8-K — filed 2026-08-06 — period 2026-08-06 — 8-K
- Form 8-K — filed 2026-06-03 — period 2026-06-02 — 8-K
- Form 8-K — filed 2026-05-29 — period 2026-05-26 — 8-K
- Form 10-Q — filed 2026-05-08 — period 2026-03-31 — 10-Q
- Form 8-K — filed 2026-05-07 — period 2026-05-07 — 8-K
- Form DEF 14A — filed 2026-04-24 — period 2026-05-26 — DEF 14A
- Form 10-K — filed 2026-02-26 — period 2025-12-31 — 10-K
- Form 8-K — filed 2026-02-25 — period 2026-02-25 — 8-K
- Form 10-Q — filed 2025-11-07 — period 2025-09-30 — 10-Q
- Form 8-K — filed 2025-11-06 — period 2025-11-06 — 8-K
- Form 8-K — filed 2025-10-27 — period 2025-10-21 — 8-K

---

Updated: 2026-10-23T05:02:54.863002+00:00

Canonical page: https://altss.com/profile/maravai-lifesciences-holdings-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology